173 related articles for article (PubMed ID: 27902461)
1. Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes.
Karyadi DM; Geybels MS; Karlins E; Decker B; McIntosh L; Hutchinson A; Kolb S; McDonnell SK; Hicks B; Middha S; FitzGerald LM; DeRycke MS; Yeager M; Schaid DJ; Chanock SJ; Thibodeau SN; Berndt SI; Stanford JL; Ostrander EA
Oncotarget; 2017 Jan; 8(1):1495-1507. PubMed ID: 27902461
[TBL] [Abstract][Full Text] [Related]
2. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.
Schaid DJ; McDonnell SK; FitzGerald LM; DeRycke L; Fogarty Z; Giles GG; MacInnis RJ; Southey MC; Nguyen-Dumont T; Cancel-Tassin G; Cussenot O; Whittemore AS; Sieh W; Ioannidis NM; Hsieh CL; Stanford JL; Schleutker J; Cropp CD; Carpten J; Hoegel J; Eeles R; Kote-Jarai Z; Ackerman MJ; Klein CJ; Mandal D; Cooney KA; Bailey-Wilson JE; Helfand B; Catalona WJ; Wiklund F; Riska S; Bahetti S; Larson MC; Cannon Albright L; Teerlink C; Xu J; Isaacs W; Ostrander EA; Thibodeau SN
Eur Urol; 2021 Mar; 79(3):353-361. PubMed ID: 32800727
[TBL] [Abstract][Full Text] [Related]
3. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C;
Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559
[TBL] [Abstract][Full Text] [Related]
5. Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility.
Fitzgerald LM; Kumar A; Boyle EA; Zhang Y; McIntosh LM; Kolb S; Stott-Miller M; Smith T; Karyadi DM; Ostrander EA; Hsu L; Shendure J; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1520-8. PubMed ID: 23833122
[TBL] [Abstract][Full Text] [Related]
6. Mutational landscape of candidate genes in familial prostate cancer.
Johnson AM; Zuhlke KA; Plotts C; McDonnell SK; Middha S; Riska SM; Schaid DJ; Thibodeau SN; Douglas JA; Cooney KA
Prostate; 2014 Oct; 74(14):1371-8. PubMed ID: 25111073
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
8. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
Na R; Wei J; Sample CJ; Gielzak M; Choi S; Cooney KA; Rabizadeh D; Walsh PC; Zheng LS; Xu J; Isaacs WB
Br J Cancer; 2022 Mar; 126(5):791-796. PubMed ID: 34799695
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.
Rand KA; Rohland N; Tandon A; Stram A; Sheng X; Do R; Pasaniuc B; Allen A; Quinque D; Mallick S; Le Marchand L; Kaggwa S; Lubwama A; ; ; Stram DO; Watya S; Henderson BE; Conti DV; Reich D; Haiman CA
Hum Mol Genet; 2016 Jan; 25(2):371-81. PubMed ID: 26604137
[TBL] [Abstract][Full Text] [Related]
10. Germline Variants of Prostate Cancer in Japanese Families.
Hayano T; Matsui H; Nakaoka H; Ohtake N; Hosomichi K; Suzuki K; Inoue I
PLoS One; 2016; 11(10):e0164233. PubMed ID: 27701467
[TBL] [Abstract][Full Text] [Related]
11. Perspective: prostate cancer susceptibility genes.
Simard J; Dumont M; Soucy P; Labrie F
Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
14. Exome Sequencing of Familial Bipolar Disorder.
Goes FS; Pirooznia M; Parla JS; Kramer M; Ghiban E; Mavruk S; Chen YC; Monson ET; Willour VL; Karchin R; Flickinger M; Locke AE; Levy SE; Scott LJ; Boehnke M; Stahl E; Moran JL; Hultman CM; Landén M; Purcell SM; Sklar P; Zandi PP; McCombie WR; Potash JB
JAMA Psychiatry; 2016 Jun; 73(6):590-7. PubMed ID: 27120077
[TBL] [Abstract][Full Text] [Related]
15. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
[TBL] [Abstract][Full Text] [Related]
16. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J
Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW
Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993
[TBL] [Abstract][Full Text] [Related]
18. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
[TBL] [Abstract][Full Text] [Related]
19. Identification of an aggressive prostate cancer predisposing variant at 11q13.
Nurminen R; Wahlfors T; Tammela TL; Schleutker J
Int J Cancer; 2011 Aug; 129(3):599-606. PubMed ID: 21064104
[TBL] [Abstract][Full Text] [Related]
20. Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact.
Cooney KA
Trans Am Clin Climatol Assoc; 2017; 128():14-23. PubMed ID: 28790484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
